Advertisement

Current Allergy and Asthma Reports

, Volume 13, Issue 3, pp 315–321 | Cite as

Ocular Myositis

  • Clare L. Fraser
  • Simon E. Skalicky
  • Avinash Gurbaxani
  • Peter McCluskey
ALLERGIC AND IMMUNOLOGIC DISORDERS OF THE EYE AND NERVOUS SYSTEM (CH KATELARIS)

Abstract

Ocular myositis frequently manifests with orbital pain and diplopia. The diagnosis of ocular myositis falls within the overall classification of idiopathic orbital inflammatory diseases, defined as non-infective non-specific orbital inflammation without identifiable local or systemic causes. Orbital myositis may form part of more widespread systemic inflammatory processes such as Crohn’s disease and the more recently described IgG4-related disease. There is also a broad range of ophthalmic differential diagnoses. Diagnosis, assessment and management of ocular myositis requires the cooperation of ophthalmologists and rheumatologists/immunologists in order to achieve the best patient outcomes. The current literature and avenues of future research are reviewed.

Keywords

Orbital myositis Extra-ocular muscle Inflammation Treatment Pathophysiology Presentation Assessment Sarcoidosis Systemic lupus erythematosus Crohn’s disease Differential diagnosis Management Corticosteroids Radiotherapy Complications Prognosis 

Notes

Disclosure

No potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Gleason J. Idiopathic myositis involving the extraocular muscles. Ophthalmol Rec. 1903;12:471–8.Google Scholar
  2. 2.
    Fujii H, Fujisada H, Kondo T, et al. Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica. 1985;190(4):230–42.PubMedCrossRefGoogle Scholar
  3. 3.
    Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;41(1):66–78.PubMedCrossRefGoogle Scholar
  4. 4.
    •• Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulins G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature? Eye. 2012;26(5):623–9. Provides an overview of the current knowledge of IgG4-related disease and orbital inflammatory disease.PubMedCrossRefGoogle Scholar
  5. 5.
    Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Yan J, Wu Z, Li Y. A clinical analysis of idiopathic orbital inflammatory pseudotumor. Yan Ke Xue Bao. 2000;16(3):208–13.PubMedGoogle Scholar
  7. 7.
    Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999;44(3):187–213.PubMedCrossRefGoogle Scholar
  8. 8.
    Schoser BG. Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and review. Clin Ophthalmol. 2007;1(1):37–42.PubMedGoogle Scholar
  9. 9.
    Culligan B. Orbital myositis following streptococcal pharyngitis in a pediatric patient. Optometry. 2005;76(4):250–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Maurer I, Zierz S. Recurrent orbital myositis: report of a familial incidence. Arch Neurol. 1999;56(11):1407–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Maalouf T, Trouchaud-Michaud C, Angioi-Duprez K, George JL. What has become of our idiopathic inflammatory pseudo-tumors of the orbit? Orbit. 1999;18(3):157–66.PubMedCrossRefGoogle Scholar
  12. 12.
    Yan J, Li Y, Qiu H, et al. Immunohistochemical study of the presence of mast cells in idiopathic orbital inflammatory pseudotumor: possible role of mast cells in the course of its pathogenesis. Int Ophthalmol. 2007;27(4):235–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord. 2006;16(4):223–36.PubMedCrossRefGoogle Scholar
  14. 14.
    Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol. 2006;2(4):219–27.PubMedCrossRefGoogle Scholar
  15. 15.
    Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg. 2006;22(2):79–86.PubMedCrossRefGoogle Scholar
  16. 16.
    Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of “idiopathic” orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012;57(1):26–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Mannor GE, Rose GE, Moseley IF, Wright JE. Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology. 1997;104(3):409–13. discussion, 14.PubMedCrossRefGoogle Scholar
  18. 18.
    Scott IU, Siatkowski RM. Idiopathic orbital myositis. Curr Opin Rheumatol. 1997;9(6):504–12.PubMedCrossRefGoogle Scholar
  19. 19.
    Browne MA, O'Keefe M, Twomey E, Donoghue V, Ryan S. A case of relapsing flitting bilateral idiopathic orbital inflammation. Pediatr Radiol. 2009;39(12):1361–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Stidham DB, Sondhi N, Plager D, Helveston E. Presumed isolated inflammation of the superior oblique muscle in idiopathic orbital myositis. Ophthalmology. 1998;105(12):2216–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Nieto JC, Kim N, Lucarelli MJ. Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol. 2008;126(8):1165–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Krasnianski M, Sievert M, Bau V, Zierz S. External ophthalmoplegia due to ocular myositis in a patient with ophthalmic herpes zoster. Neuromuscul Disord. 2004;14(7):438–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Huerva V, Espinet R, Galindo C. Recurrent orbital inflammation and Whipple disease. Ocul Immunol Inflamm. 2008;16(1):37–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Kokotis P, Theodossiadis P, Bouros C, Sfikakis PP. Bilateral ocular myositis as a late complication of dermatomyositis. J Rheumatol. 2005;32(2):379–81.PubMedGoogle Scholar
  25. 25.
    Attarian S, Fernandez C, Azulay J, et al. Clinical and radiological features and clinical course of orbital myositis. Rev Neurol (Paris). 2003;159(3):307–12.Google Scholar
  26. 26.
    Raskin EM, McCormick SA, Maher EA, Della Rocca RC. Granulomatous idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 1995;11(2):131–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86(5):648–55.PubMedGoogle Scholar
  28. 28.
    Culver EL, Salmon JF, Frith P, Travis SP. Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn's disease: case report and systematic literature review. J Crohns Colitis. 2008;2(4):337–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Hernandez-Garfella ML, Gracia-Garcia A, Cervera-Taulet E, Garcia-Villanueva C, Montero-Hernandez J. Adalimumab for recurrent orbital myositis in Crohn's disease: report of a case with a 3-year follow-up. J Crohns Colitis. 2011;5(3):265–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Pimentel R, Lago P, Pedroto I. Recurrent orbital myositis as an extra-intestinal manifestation of Crohn's disease. J Crohns Colitis. 2012;6(9):958–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Bourikas LA, Roussomoustakaki M, Papadaki E, et al. A case of orbital myositis preceding the intestinal symptoms of Crohn's disease. J Crohns Colitis. 2010;4(3):349–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Mahr A, Katsahian S, Varet H, et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2012. Sept 8. Epub ahead of print.Google Scholar
  33. 33.
    Fechner FP, Faquin WC, Pilch BZ. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients. Laryngoscope. 2002;112(11):1945–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Salam A, Meligonis G, Malhotra R. Superior oblique myositis as an early feature of orbital Wegener's granulomatosis. Orbit. 2008;27(3):203–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012;96(2):311–28.PubMedCrossRefGoogle Scholar
  36. 36.
    Seltz LB, Smith J, Durairaj VD, Enzenauer R, Todd J. Microbiology and antibiotic management of orbital cellulitis. Pediatrics. 2011;127(3):e566–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Dewan MA, Meyer DR, Wladis EJ. Orbital cellulitis with subperiosteal abscess: demographics and management outcomes. Ophthal Plast Reconstr Surg. 2011;27(5):330–2.PubMedCrossRefGoogle Scholar
  38. 38.
    Acharya IG, Jethani J. Pyomyositis of extraocular muscle: case series and review of the literature. Indian J Ophthalmol. 2010;58(6):532–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Varma A, Sharma K, Rathi B, Gupta RK, Malik V. Isolated abscess of extraocular muscle in two young boys: clinical and imaging features. Orbit. 2003;22(1):67–72.PubMedCrossRefGoogle Scholar
  40. 40.
    Haufschild T, Weber P, Nuttli I, et al. Idiopathic isolated abscess in an extraocular muscle in a child. Arch Ophthalmol. 2004;122(8):1233–4.PubMedCrossRefGoogle Scholar
  41. 41.
    Grouteau E, Chaix Y, Armbruster V, et al. Acute orbital myositis and idiopathic inflammatory pseudotumor in children: three cases. Arch Pediatr. 1998;5(2):153–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37(4):207–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Capone Jr A, Slamovits TL. Discrete metastasis of solid tumors to extraocular muscles. Arch Ophthalmol. 1990;108(2):237–43.PubMedCrossRefGoogle Scholar
  44. 44.
    Kubota T, Kano H. Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-weighted magnetic resonance imaging. Am J Ophthalmol. 2007;143(4):718–20.PubMedCrossRefGoogle Scholar
  45. 45.
    Frohman LP, Kupersmith MJ, Lang J, et al. Intracranial extension and bone destruction in orbital pseudotumor. Arch Ophthalmol. 1986;104(3):380–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol. 2012;96(2):276–80.PubMedCrossRefGoogle Scholar
  47. 47.
    Gumus K, Mirza GE, Cavanagh HD, Karakucuk S. Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature. Eye Contact Lens. 2009;35(5):275–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Shah SS, Lowder CY, Schmitt MA, Wilke WS, Kosmorsky GS, Meisler DM. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 1992;99(9):1419–23.PubMedGoogle Scholar
  49. 49.
    Magrini L, Rotiroti G, Conti F, et al. Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids. Isr Med Assoc J. 2003;5(11):825–6.PubMedGoogle Scholar
  50. 50.
    • Aggarwal R, Oddis C. Therapeutic advances in myositis. Curr Opin Rheumatol. 2012. This is an excellent overview for all types of mysoitis treatments.Google Scholar
  51. 51.
    Criscione LG, St Clair EW. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol. 2002;14(3):204–11.PubMedCrossRefGoogle Scholar
  52. 52.
    Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138(6):925–30.PubMedCrossRefGoogle Scholar
  53. 53.
    Lanciano R, Fowble B, Sergott RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18(2):407–11.PubMedCrossRefGoogle Scholar
  54. 54.
    Keleti D, Flickinger JC, Hobson SR, Mittal BB. Radiotherapy of lymphoproliferative diseases of the orbit. Surveillance of 65 cases. Am J Clin Oncol. 1992;15(5):422–7.PubMedGoogle Scholar
  55. 55.
    Weinstein GS, Dresner SC, Slamovits TL, Kennerdell JS. Acute and subacute orbital myositis. Am J Ophthalmol. 1983;96(2):209–17.PubMedGoogle Scholar
  56. 56.
    • Matthiesen C, Bogardus Jr C, Thompson JS, Farris B, Hildebrand L, Wilkes B, et al. The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys. 2011;79(5):1496–502. Though this is a single-center retrospective review article, it assesses the outcomes of modern radiotherapy treatment in orbital inflammatory disease.PubMedCrossRefGoogle Scholar
  57. 57.
    Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997;104(3):402–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Isobe K, Uno T, Kawakami H, et al. Radiation therapy for idiopathic orbital myositis: two case reports and literature review. Radiat Med. 2004;22(6):429–31.PubMedGoogle Scholar
  59. 59.
    Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103(3):521–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Clare L. Fraser
    • 1
    • 2
  • Simon E. Skalicky
    • 1
    • 2
  • Avinash Gurbaxani
    • 1
    • 2
  • Peter McCluskey
    • 1
    • 2
  1. 1.Department of Ophthalmology, Faculty of MedicineUniversity of SydneySydneyAustralia
  2. 2.c/o Save Sight InstituteSydney Eye HospitalSydneyAustralia

Personalised recommendations